Lv4
570 积分 2023-06-06 加入
Dupilumab-related eosinophilia in patients with severe asthma: Post-marketing surveillance in Japan
4个月前
已完结
Long‐term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3‐year real‐life study
4个月前
已完结
Three-Year Observational Study on the Long-Term Efficacy and Safety of Dupilumab in Elderly Patients with Severe Atopic Dermatitis
4个月前
已完结
Efficacy and safety of dupilumab in patients with prurigo nodularis
4个月前
已完结
Dual checkpoint inhibition in gallbladder cancer: Bridging new hope with the need for biomarkers
5个月前
已完结
Dupilumab in atopic-dermatitis-like eczema associated with inborn errors of immunity: a nationwide study
5个月前
已完结
Concurrent therapy with dupilumab and infliximab for atopic dermatitis and Crohn's disease
5个月前
已关闭
Erythema nodosum of the extremities following dupilumab treatment in a patient with atopic dermatitis
5个月前
已完结
Two studies of nerve growth factor (NGF) inhibitors implemented a rigorous mitigation plan to exclude OA patients with a risk of joint collapse, but it was still not enough!
6个月前
已完结
Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum
7个月前
已完结
皖公网安备34019202002308
